Clinical data governance: Vetting the value of participation

As a first step in an enterprise approach to clinical management, health systems must create a governance process to determine what measures will truly impact their performance.

Key findings:
There are many opportunities to realize the value of participation in registries outside the clinical insights. In fact, the competitive advantages have become almost equally as important. There are resources and partnerships available to help maximize value, and Q-Centrix is one of them.

Download the White Paper

"*" indicates required fields

This field is for validation purposes and should be left unchanged.